Lapse-supported life insurance and adverse selection

Oytun Haçarız,Torsten Kleinow,Angus S. Macdonald
2024-09-03
Abstract:If individuals at the highest mortality risk are also least likely to lapse a life insurance policy, then lapse-supported premiums magnify adverse selection costs. As an example, we model 'Term to 100' contracts, and risk as revealed by genetic test results. We identify three methods of managing lapse surplus: eliminating it by design; disposing of it retrospectively (through participation); or disposing of it prospectively (through lapse-supported premiums). We then assume a heterogeneous population in which: (a) insurers cannot identify individuals at high mortality risk; (b) a secondary market exists that prevents high-risk policies from lapsing; (c) financial underwriting is lax or absent; and (d) life insurance policies may even be initiated by third parties as a financial investment (STOLI). Adverse selection losses under (a) are typically very small, but under (b) can be increased by multiples, and under (c) and (d) increased almost without limit. We note that the different approaches to modeling lapses used in studies of adverse selection and genetic testing appear to be broadly equivalent and robust.
Risk Management
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper attempts to explore what might happen when two modern life insurance features—lapse-supported premiums and adverse selection—collide. Specifically, the paper focuses on: 1. **Lapse-Supported Premiums**: This premium structure allows insurance companies to pre-commit future lapse profits, thereby reducing contract premiums. For example, the "Term to 100" contract, common in Canada, is a typical example. 2. **Adverse Selection**: If high-risk individuals (i.e., those with higher mortality rates) are less likely to lapse, lapse-supported premiums will exacerbate the costs of adverse selection. The paper reveals risks through genetic test results, assuming that insurance companies cannot identify high-risk individuals, but a secondary market exists to prevent high-risk policy lapses. The main issues addressed in the paper include: - **How to Manage Lapse Profits**: The paper proposes three methods: eliminating lapse profits by design, ex-post distribution (through a participation mechanism), or ex-ante distribution (through lapse-supported premiums). - **Impact of Adverse Selection**: How the costs of adverse selection change under different conditions (e.g., insurance companies cannot identify high-risk individuals, the existence of a secondary market, lenient or absent financial underwriting, third parties initiating policies as financial investments). - **Robustness of Models**: Whether the lapse models used in different studies to analyze adverse selection and genetic testing are equivalent and robust. ### Main Contributions of the Paper - **Theoretical Analysis**: The paper uses mathematical models and economic arguments to analyze the impact of lapse-supported premiums on the adverse selection risk faced by insurance companies. - **Practical Application**: The paper provides specific numerical examples showing the changes in lapse-supported premiums under different lapse rates and interest rates and their impact on insurance company profits. - **Policy Recommendations**: The paper discusses the impact of prohibiting insurance companies from using genetic test results on the life insurance industry and proposes some coping strategies. ### Conclusion The paper aims to answer two main questions: 1. How do lapse-supported premiums affect insurance companies' exposure to adverse selection risk? 2. How robust are the conclusions of recent models used to illustrate the impact of prohibiting insurance companies from accessing genetic test results? Through these questions, the paper provides important theoretical and empirical evidence for understanding and addressing complex issues in modern life insurance.